-
1
-
-
23044494423
-
Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8
-
DOI 10.1016/j.bbrc.2005.07.002, PII S0006291X05014452
-
P. Rathanaswami, S. Roalstad, L. Roskos, Q.J. Su, S. Lackie, J. Babcook, Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8, Biochem. Biophys. Res. Commun. 334 (2005) 1004-1013. (Pubitemid 41074676)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.334
, Issue.4
, pp. 1004-1013
-
-
Rathanaswami, P.1
Roalstad, S.2
Roskos, L.3
Su, Q.J.4
Lackie, S.5
Babcook, J.6
-
2
-
-
0034671357
-
Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model
-
L.S. Zuckier, E.Z. Berkowitz, R.J. Sattenberg, Q.H. Zhao, H.F. Deng, M.D. Scharff, Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model, Cancer Res. 60 (2000) 7008-7013. (Pubitemid 32059177)
-
(2000)
Cancer Research
, vol.60
, Issue.24
, pp. 7008-7013
-
-
Zuckier, L.S.1
Berkowitz, E.Z.2
Sattenberg, R.J.3
Quing, H.Z.4
Hou, F.D.5
Scharff, M.D.6
-
3
-
-
0021016543
-
Direct binding of radioiodinated monoclonal antibody to tumor cells: Significance of antibody purity and affinity for drug targeting or tumor imaging
-
S.J. Kennel, L.J. Foote, P.K. Lankford, M. Johnson, T. Mitchell, G.R. Braslawsky, Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting or tumor imaging, Hybridoma 2 (1983) 297-310. (Pubitemid 14176978)
-
(1983)
Hybridoma
, vol.2
, Issue.3
, pp. 297-310
-
-
Kennel, S.J.1
Foote, L.J.2
Lankford, P.K.3
-
4
-
-
48249146140
-
Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors
-
Y.N. Abdiche, D.S. Malashock, J. Pons, Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors, Protein Sci. 17 (2008) 1326-1335.
-
(2008)
Protein Sci.
, vol.17
, pp. 1326-1335
-
-
Abdiche, Y.N.1
Malashock, D.S.2
Pons, J.3
-
5
-
-
78650894342
-
Survey of the year 2009: Applications of isothermal titration calorimetry
-
R.J. Falconer, B.M. Collins, Survey of the year 2009: applications of isothermal titration calorimetry, J. Mol. Recognit. 24 (2011) 1-16.
-
(2011)
J. Mol. Recognit.
, vol.24
, pp. 1-16
-
-
Falconer, R.J.1
Collins, B.M.2
-
6
-
-
14644433149
-
Kinetic exclusion assay technology: Characterization of molecular interactions
-
R.J. Darling, P.A. Brault, Kinetic exclusion assay technology: characterization of molecular interactions, Assay Drug Dev. Technol. 2 (2004) 647-657.
-
(2004)
Assay Drug Dev. Technol.
, vol.2
, pp. 647-657
-
-
Darling, R.J.1
Brault, P.A.2
-
7
-
-
37049021526
-
High-affinity binding measurements of antibodies to cell-surface- expressed antigens
-
P. Rathanaswami, J. Babcook, M. Gallo, High-affinity binding measurements of antibodies to cell-surface-expressed antigens, Anal. Biochem. 373 (2008) 52-60.
-
(2008)
Anal. Biochem.
, vol.373
, pp. 52-60
-
-
Rathanaswami, P.1
Babcook, J.2
Gallo, M.3
-
8
-
-
22144473731
-
Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A
-
A. Razai, C. Garcia-Rodriguez, J. Lou, I.N. Geren, C.M. Forsyth, Y. Robles, R. Tsai, T.J. Smith, L.A. Smith, R.W. Siegel, M. Feldhaus, J.D. Marks, Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A, J. Mol. Biol. 351 (2005) 158-169.
-
(2005)
J. Mol. Biol.
, vol.351
, pp. 158-169
-
-
Razai, A.1
Garcia-Rodriguez, C.2
Lou, J.3
Geren, I.N.4
Forsyth, C.M.5
Robles, Y.6
Tsai, R.7
Smith, T.J.8
Smith, L.A.9
Siegel, R.W.10
Feldhaus, M.11
Marks, J.D.12
-
9
-
-
0027963484
-
Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs
-
L.L. Green, M.C. Hardy, C.E. Maynard-Currie, H. Tsuda, D.M. Louie, M.J. Mendez, H. Abderrahim, M. Noguchi, D.H. Smith, Y. Zeng, et al., Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs, Nat. Genet. 7 (1994) 13-21.
-
(1994)
Nat. Genet.
, vol.7
, pp. 13-21
-
-
Green, L.L.1
Hardy, M.C.2
Maynard-Currie, C.E.3
Tsuda, H.4
Louie, D.M.5
Mendez, M.J.6
Abderrahim, H.7
Noguchi, M.8
Smith, D.H.9
Zeng, Y.10
-
10
-
-
60849128549
-
Monoclonal antibodies as innovative therapeutics
-
J.M. Reichert, Monoclonal antibodies as innovative therapeutics, Curr. Pharm. Biotechnol. 9 (2008) 423-430.
-
(2008)
Curr. Pharm. Biotechnol.
, vol.9
, pp. 423-430
-
-
Reichert, J.M.1
-
11
-
-
24344483518
-
New treatments for SLE: Cell-depleting and anti-cytokine therapies
-
DOI 10.1016/j.berh.2005.05.006, PII S1521694205000707
-
J.H. Anolik, M. Aringer, New treatments for SLE: cell-depleting and anticytokine therapies, Best Pract. Res. Clin. Rheumatol. 19 (2005) 859-878. (Pubitemid 41258587)
-
(2005)
Best Practice and Research: Clinical Rheumatology
, vol.19
, Issue.5 SPEC. ISS
, pp. 859-878
-
-
Anolik, J.H.1
Aringer, M.2
-
12
-
-
33646078924
-
Therapeutic potential of cytokine and chemokine antagonists in cancer therapy
-
L. Yan, G.M. Anderson, M. DeWitte, M.T. Nakada, Therapeutic potential of cytokine and chemokine antagonists in cancer therapy, Eur. J. Cancer 42 (2006) 793-802.
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 793-802
-
-
Yan, L.1
Anderson, G.M.2
DeWitte, M.3
Nakada, M.T.4
-
13
-
-
0842348085
-
Anti-cytokine Ab immune therapy: Present status and perspectives
-
DOI 10.1016/S1359-6446(03)02955-6, PII S1359644603029556
-
D. Zagury, R.C. Gallo, Anti-cytokine Ab immune therapy: present status and perspectives, Drug Discov. Today 9 (2004) 72-81. (Pubitemid 38169531)
-
(2004)
Drug Discovery Today
, vol.9
, Issue.2
, pp. 72-81
-
-
Zagury, D.1
Gallo, R.C.2
-
14
-
-
0031722518
-
The role of IL-13 and its receptor in allergy and inflammatory responses
-
J.E. de Vries, The role of IL-13 and its receptor in allergy and inflammatory responses, J. Allergy Clin. Immunol. 102 (1998) 165-169.
-
(1998)
J. Allergy Clin. Immunol.
, vol.102
, pp. 165-169
-
-
De Vries, J.E.1
-
15
-
-
0032545433
-
Requirement for IL-13 independently of IL-4 in experimental asthma
-
DOI 10.1126/science.282.5397.2261
-
G. Grunig, M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, D. Sheppard, M. Mohrs, D.D. Donaldson, R.M. Locksley, D.B. Corry, Requirement for IL-13 independently of IL-4 in experimental asthma, Science 282 (1998) 2261-2263. (Pubitemid 29004075)
-
(1998)
Science
, vol.282
, Issue.5397
, pp. 2261-2263
-
-
Grunig, G.1
Warnock, M.2
Wakil, A.E.3
Venkayya, R.4
Brombacher, F.5
Rennick, D.M.6
Sheppard, D.7
Mohrs, M.8
Donaldson, D.D.9
Locksley, R.M.10
Corry, D.B.11
-
16
-
-
24344439743
-
Measurement of the functional affinity constant of a monoclonal antibody for cell surface receptors using kinetic exclusion fluorescence immunoassay
-
DOI 10.1016/j.jim.2005.04.009, PII S002217590500116X
-
L. Xie, R. Mark Jones, T.R. Glass, R. Navoa, Y. Wang, M.J. Grace, Measurement of the functional affinity constant of a monoclonal antibody for cell surface receptors using kinetic exclusion fluorescence immunoassay, J. Immunol. Methods 304 (2005) 1-14. (Pubitemid 41262216)
-
(2005)
Journal of Immunological Methods
, vol.304
, Issue.1-2
, pp. 1-14
-
-
Xie, L.1
Jones, R.M.2
Glass, T.R.3
Navoa, R.4
Wang, Y.5
Grace, M.J.6
|